Basilea Pharmaceutica Ltd (XSWX:BSLN)
CHF 53.1 -1.6 (-2.93%) Market Cap: 657.20 Mil Enterprise Value: 586.62 Mil PE Ratio: 16.91 PB Ratio: 5.11 GF Score: 59/100

Basilea Pharmaceutica Ltd (XSWX:BSLN) Transcripts

  • 1